Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
about
Importance of Lid Hygiene Before Ocular Surgery: Qualitative and Quantitative Analysis of Eyelid and Conjunctiva Microbiota.Post-intravitreal anti-VEGF endophthalmitis in the United Kingdom: incidence, features, risk factors, and outcomes.Incidence of Endophthalmitis after Intravitreal Bevacizumab using Aliquots Prepared On-site in 2 Operating Rooms in KuwaitLong-term outcome of intravitreal ranibizumab treatment, compared with photodynamic therapy, in patients with polypoidal choroidal vasculopathy.The microbiology of endophthalmitis: global trends and a local perspective.Current Perspectives of Prophylaxis and Management of Acute Infective Endophthalmitis.Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask.Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes.Predictive factors for recurrence of macular edema after successful intravitreal bevacizumab therapy in branch retinal vein occlusion.Postoperative endophthalmitis incidence after intravitreal therapy: a comparison of two different preoperative antibiotic prophylaxis.Prospective comparison of low-fluence photodynamic therapy combined with intravitreal bevacizumab versus bevacizumab monotherapy for choroidal neovascularization in age-related macular degeneration.Intravitreal Injection of Anti-vascular Endothelial Growth Factor Agents for Ocular Vascular Diseases: Clinical Practice Guideline.
P2860
Q35866525-A69F3480-3597-4679-8467-78DB243B94EAQ36468197-74888383-FC3F-45A3-BD57-6D4E948F00DEQ36596479-7ECA6D34-2236-4F5E-AC43-35B0226799F5Q37168836-46A637B1-0E10-4BEA-8023-DD140EC3C6D9Q38016095-3EB739A3-ACFE-4CA9-A147-5811C1D758E5Q38758366-F7D941A1-36A4-4D97-8847-7E00C1537C2CQ42276004-622D16DD-C22E-41C4-9590-D91229A2ADECQ49197963-99803A87-8992-404D-99F7-EDB00C330D72Q50564863-1F612926-BD5B-487A-B237-04DB12A066AAQ51537659-2EED8EB1-0F16-4B9F-ABF1-D89C7C9C5015Q54778471-E9B8DA04-9820-44A8-8B43-47286708EA8EQ54942391-00C59797-ADC9-40D7-9066-5616B63FE797
P2860
Evaluation of the incidence of endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Evaluation of the incidence of ...... lar endothelial growth factor.
@en
Evaluation of the incidence of ...... lar endothelial growth factor.
@nl
type
label
Evaluation of the incidence of ...... lar endothelial growth factor.
@en
Evaluation of the incidence of ...... lar endothelial growth factor.
@nl
prefLabel
Evaluation of the incidence of ...... lar endothelial growth factor.
@en
Evaluation of the incidence of ...... lar endothelial growth factor.
@nl
P2093
P2860
P356
P1433
P1476
Evaluation of the incidence of ...... lar endothelial growth factor.
@en
P2093
Chie Sotozono
Hideki Komori
Hiroyuki Matsushima
Kazuaki Kadonosono
Kumiko Tanaka
Maiko Inoue
Shigeru Kinoshita
Shinichiro Kobayakawa
Tadashi Senoo
Tetsuo Tochikubo
P2860
P304
P356
10.1159/000329863
P577
2011-07-29T00:00:00Z